Evolution Wealth Advisors, LLC Ascendis Pharma A/S Transaction History

Evolution Wealth Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$127.1 - $169.66 $11,184 - $14,930	-88 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$112.67 - $176.92 $13,858 - $21,761	-123 Reduced 58.29%	88 $14,000
Q1 2021 Apr 20, 2021	BUY	$124.92 - $173.33 $999 - $1,386	8 Added 3.94%	211 $27,000
Q4 2020 Feb 02, 2021	SELL	$151.2 - $182.76 $4,989 - $6,031	-33 Reduced 13.98%	203 $34,000
Q3 2020 Oct 15, 2020	BUY	$134.29 - $154.32 $3,357 - $3,858	25 Added 11.85%	236 $36,000
Q2 2020 Jul 27, 2020	SELL	$110.87 - $156.01 $1,663 - $2,340	-15 Reduced 6.64%	211 $31,000
Q1 2020 Apr 22, 2020	BUY	$97.01 - $145.11 $3,492 - $5,223	36 Added 18.95%	226 $25,000
Q4 2019 Feb 03, 2020	BUY	$91.45 - $139.12 $17,375 - $26,432	190 New	190 $26,000

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.